Gersh Kuntzman, deputy politics editor at Newsweek, discusses President Trump's remarks on the Parkland school shooting that left 17 students and faculty members dead. President Trump made headlines when he failed to even use the word "gun" in his speech following the massacre.
Kuntzman says he doesn't believe anything will change with this latest shooting, at least not under the current administration and a Republican-controlled Congress.
Texas is lifting a COVID-19 mask mandate that was imposed last summer but has only been lightly enforced. Republican Gov. Greg Abbott’s announcement Tuesday makes Texas the largest state to do away with a face covering order.
Drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly.
Calls for New York Gov. Andrew Cuomo to resign are intensifying now that a third woman has accused him of offensive behavior.
The pill comprises 40% of the profits in the U.S. contraceptive market and 25% of contraceptive consumers, causing millions of unnecessary ‘periods’ along the way. So, why hasn’t birth control evolved beyond the pseudo-period?
This is your Washington Week Ahead for the week of March 1.
U.S. health advisers have endorsed a one-dose COVID-19 vaccine from Johnson & Johnson that's expected to provide an easier-to-use option to fight the pandemic.
Following the Senate Intelligence Committee hearing on the widespread SolarWinds cyberattack, cybersecurity experts are pushing the need for private businesses and federal agencies to cooperate closely to prevent future such breaches.
From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.
Andy Purdy, chief security officer for the company's U.S. division, refuted reports that Huawei would be manufacturing electric cars of its own.
Democrats are looking to Biden to aggressively pursue judicial appointments following Trump's rapid rate of picks. Advocates point to some early signs that the new president may be following their lead.
